Search Results - Le Bruchec, Yvan

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study

    Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study by Awad, Mark M, Le Bruchec, Yvan, Lu, Brian, Ye, Jason, Miller, JulieAnn, Lizotte, Patrick H, Cavanaugh, Megan E, Rode, Amanda J, Dumitru, Calin Dan, Spira, Alexander

    Published in Frontiers in oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Phase Ib Study of the Histone Deacetylase 6 Inhibitor Citarinostat in Combination With Paclitaxel in Patients With Advanced Solid Tumors

    Phase Ib Study of the Histone Deacetylase 6 Inhibitor Citarinostat in Combination With Paclitaxel in Patients With Advanced Solid Tumors by Gordon, Michael S, Shapiro, Geoffrey I, Sarantopoulos, John, Juric, Dejan, Lu, Brian, Zarotiadou, Angeliki, Connarn, Jamie N, Le Bruchec, Yvan, Dumitru, Calin Dan, Harvey, R Donald

    Published in Frontiers in oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study

    Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study by Awad, Mark M., Le Bruchec, Yvan, Lu, Brian, Ye, Jason, Miller, Julie Ann, Lizotte, Patrick H., Cavanaugh, Megan E., Rode, Amanda J., Dumitru, Calin Dan, Spira, Alexander

    Published in Frontiers in oncology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network

    Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaborati... by Amoroso, Loredana, Castel, Victoria, Bisogno, Gianni, Casanova, Michela, Marquez-Vega, Catalina, Chisholm, Julia C., Doz, François, Moreno, Lucas, Ruggiero, Antonio, Gerber, Nicolas U., Fagioli, Franca, Hingorani, Pooja, Melcón, Soledad G., Slepetis, Ruta, Chen, Nianhang, le Bruchec, Yvan, Simcock, Mathew, Vassal, Gilles

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer

    Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for childre... by Moreno, Lucas, Casanova, Michela, Chisholm, Julia C., Berlanga, Pablo, Chastagner, Pascal B., Baruchel, Sylvain, Amoroso, Loredana, Gallego Melcón, Soledad, Gerber, Nicolas U., Bisogno, Gianni, Fagioli, Franca, Geoerger, Birgit, Glade Bender, Julia L., Aerts, Isabelle, Bergeron, Christophe, Hingorani, Pooja, Elias, Ileana, Simcock, Mathew, Ferrara, Stefano, Le Bruchec, Yvan, Slepetis, Ruta, Chen, Nianhang, Vassal, Gilles

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: